A. Schrattenholz

M. Heilemann, G. Schwall, S. Liebner, 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Determination of fractional synthesis rates of mouse hepatic proteins via metabolic 13C-labeling, MALDI-TOF MS and analysis of relative isotopologue abundances using average masses.

G. Schwall, M. Cahill, A. Schrattenholz, 2005, Analytical chemistry.

The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy.

Karl-Heinz Krause, Michel Puceat, Marcel Leist, 2008, ALTEX.

Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells.

A. Maelicke, E. Albuquerque, E. Pereira, 1995, European journal of pharmacology.

Nicotinic acetylcholine receptors on hippocampal neurons: distribution on the neuronal surface and modulation of receptor activity.

A. Maelicke, E. Albuquerque, E. Pereira, 1997, Journal of receptor and signal transduction research.

Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function.

E X Albuquerque, H. Eisenberg, A. Maelicke, 1997, The Journal of pharmacology and experimental therapeutics.

Isolation, structural and toxicological characterization of three new mycotoxins produced by the fungusAureobasidium pullulans

A. Schrattenholz, P. Flesch, 1993, Mycotoxin Research.

The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation.

Marcel Leist, A. Henn, M. Leist, 2009, ALTEX.

Nonenzymatic posttranslational protein modifications in ageing

K. Groebe, A. Schrattenholz, V. Soskic, 2008, Experimental Gerontology.

A novel agonist binding site on nicotinic acetylcholine receptors.

A. Maelicke, E. Albuquerque, E. Pereira, 1993, Journal of receptor research.

Systems biology approaches and tools for analysis of interactomes and multi-target drugs.

André Schrattenholz, Karlfried Groebe, Vukic Soskic, 2010, Methods in molecular biology.

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

E. Albuquerque, B. Schröder, E. Pereira, 2002 .

Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing.

Tanja Waldmann, Karl-Heinz Krause, Marcel Leist, 2010, ALTEX.

Autocatalytic cleavage of Clostridium difficile toxin B

S. Tenzer, H. Schild, M. Rupnik, 2007, Nature.

Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection.

H. Klocker, W. Horninger, K. Miller, 2009, The Journal of urology.

Comparison of different separation technologies for proteome analyses: isoform resolution as a prerequisite for the definition of protein biomarkers on the level of posttranslational modifications.

André Schrattenholz, G. Schwall, A. Schrattenholz, 2006, Journal of chromatography. A.

Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: Cancer association of annexin A3

H. Klocker, K. Dietz, G. Schaefer, 2007, Proteomics.

Proteomic expression profiling of breast cancer.

T. Fehm, R. Kurek, R. Speer, 2007, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Breast cancer proteomics by laser capture microdissection, sample pooling, 54‐cm IPG IEF, and differential iodine radioisotope detection

T. Fehm, D. Wallwiener, A. Nordheim, 2006, Electrophoresis.

The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia‐ischemia as potently as erythropoietin

Changlian Zhu, K. Blomgren, M. Leist, 2004, Journal of neurochemistry.

Biochemical characterization of a novel channel-activating site on nicotinic acetylcholine receptors.

A. Maelicke, E. Albuquerque, B. Schröder, 1993, Journal of receptor research.

Physostigmine and Neuromuscular Transmission a

A. Maelicke, E. Albuquerque, B. Schröder, 1993, Annals of the New York Academy of Sciences.

Mammalian DNMTs in the male germ line DNA of Drosophila.

Xiaojing Tang, Guoliang Xu, A. Schrattenholz, 2008, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Investigating the neuroprotective mechanism of action of a CDK5 inhibitor by phosphoproteome analysis

B. Sommer, F. Gillardon, A. Schrattenholz, 2005, Journal of cellular biochemistry.

Differential proteomic profiling of mitochondria from Podospora anserina, rat and human reveals distinct patterns of age-related oxidative changes

Heinz D. Osiewacz, André Schrattenholz, Karlfried Groebe, 2007, Experimental Gerontology.

Analysis of relative isotopologue abundances for quantitative profiling of complex protein mixtures labelled with the acrylamide/D3-acrylamide alkylation tag system.

G. Schwall, M. Cahill, A. Schrattenholz, 2003, Rapid communications in mass spectrometry : RCM.

Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease

P. Brundin, A. Schrattenholz, G. Höglinger, 2012, Neuroscience Letters.

Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease

P. Brundin, G. Schwall, K. Groebe, 2011, Journal of neurochemistry.

Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.

A. Schrattenholz, V. Soskic, S. Kostic-Rajacic, 2005, European journal of medicinal chemistry.

Protein abundance quantification in embryonic stem cells using incomplete metabolic labelling with 15N amino acids, matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry, and analysis of relative isotopologue abundances of peptides.

M. Cahill, A. Schrattenholz, K. Hölzer, 2003, Rapid communications in mass spectrometry : RCM.

Protein biomarkers for in vitro testing of embryotoxicity.

A. K. Peters, G. Schwall, K. Hayess, 2010, Journal of proteome research.

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer’s disease

A. Maelicke, M. Samochocki, E. Albuquerque, 2000, Behavioural Brain Research.

The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions

Jeppe Falsig, Marcel Leist, André Schrattenholz, 2006, Journal of Neuroimmunology.

Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine.

E X Albuquerque, J Godovac-Zimmermann, A. Maelicke, 1993, European journal of biochemistry.

What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers

André Schrattenholz, Karlfried Groebe, K. Groebe, 2007, Electrophoresis.

Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.

E X Albuquerque, A. Maelicke, E. Albuquerque, 1996, Molecular pharmacology.

Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.

A. Maelicke, E. Albuquerque, E. Pereira, 1993, The Journal of pharmacology and experimental therapeutics.

What does systems biology mean for drug development?

André Schrattenholz, A. Schrattenholz, Vukić Soskić, 2008, Current medicinal chemistry.

Neuronal Nicotinic Receptors in the Locust Locusta migratoria

A. Maelicke, A. Schrattenholz, S. Reinhardt, 1998, The Journal of Biological Chemistry.

Synchronization of posttranslational modifications during aging

André Schrattenholz, Karlfried Groebe, K. Groebe, 2010, Annals of the New York Academy of Sciences.

Neuronal Nicotinic Acetylcholine Receptors in Non-neuronal Cells, Expression and Renaturation of Ligand Binding Domain, and Modulatory Control by Allosterically Acting Ligands

A. Maelicke, E. Albuquerque, A. Schrattenholz, 2000 .

Proteomics: how to control highly dynamic patterns of millions of molecules and interpret changes correctly?

André Schrattenholz, A. Schrattenholz, 2004, Drug discovery today. Technologies.

Comparative profiling of the mammalian mitochondrial proteome: multiple aconitase-2 isoforms includi

G. Schwall, H. Osiewacz, M. Cahill, 2006 .

A connection between the mitochondrial permeability transition pore, autophagy, and cerebral amyloidogenesis.

André Schrattenholz, Karlfried Groebe, G. Schwall, 2008, Journal of proteome research.

Unexpected common mechanistic pathways for embryotoxicity of warfarin and lovastatin.

Katrin Hayess, Annelieke K Peters, Margino Steemans, 2010, Reproductive toxicology.

Stable expression in HEK‐293 cells of the rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor

A. Maelicke, A. Schrattenholz, C. Methfessel, 1996 .

Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.

N. Toni, J. Cirrito, S. Liebner, 2013, Journal of Alzheimer's disease : JAD.

Neuronal cell culture from human embryonic stem cells as in vitro model for neuroprotection.

André Schrattenholz, A. Schrattenholz, Martina Klemm, 2007, ALTEX.

Differential radioactive proteomic analysis of microdissected renal cell carcinoma tissue by 54 cm isoelectric focusing in serial immobilized pH gradient gels.

R. Burgemeister, R. Gangnus, G. Schwall, 2005, Journal of proteome research.

Identification of purine binding sites on Torpedo acetylcholine receptor.

A. Maelicke, E. Albuquerque, A. Schrattenholz, 1994, Journal of receptor research.

Molecular analysis of homocysteic acid-induced neuronal stress.

G. Schwall, A. Schrattenholz, S. Sommer, 2004, Journal of proteome research.

Stem cells in head and neck squamous cell carcinoma.

A. Schrattenholz, K. Shakib, V. Soskic, 2011, The British journal of oral & maxillofacial surgery.

How Human Embryonic Stem Cell Research Can Impact In‐Vitro Drug Screening Technologies of the Future

André Schrattenholz, A. Schrattenholz, Martina Klemm, 2006 .

NMDA receptors are not alone: dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signalling.

André Schrattenholz, A. Schrattenholz, Vukic Soskic, 2006, Current topics in medicinal chemistry.

Integrative proteomics: functional and molecular characterization of a particular glutamate-related neuregulin isoform.

J. Kriegsmann, W. Schmidt, A. Schrattenholz, 2005, Journal of proteome research.

Comparative profiling of the mammalian mitochondrial proteome: multiple aconitase-2 isoforms including N-formylkynurenine modifications as part of a protein biomarker signature for reactive oxidative species.

G. Schwall, H. Osiewacz, M. Cahill, 2006, Journal of proteome research.

Neurotoxicity of active compounds--establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity screening and biomarker identification.

André Schrattenholz, A. Schrattenholz, Martina Klemm, 2004, ALTEX.

Adsorption of functionalized biomembrane vesicles on crystalline surfaces monitored by FTIR- and Surface Enhanced FTIR Spectroscopy

P. Nollert, R. Salzer, G. Steiner, 1997 .

Synchronization of posttranslational modifications during aging

K. Groebe, A. Schrattenholz, V. Soskic, 2010, Annals of the New York Academy of Sciences.